Administration of DHEA augments progesterone production in a woman with low ovarian reserve being transplanted with cryopreserved ovarian tissue

Journal of Assisted Reproduction and Genetics

Volumn 31, Issue 6, 2014, Pages 645-649

  Strauss, Susanne ^a   Greve, Tine ^a   Ernst, Erik ^b   Fraidakis, Matthiaos ^c   Grudzinskas, Jurgis Gedis ^d   Andersen, Claus Yding ^a,e  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c Crete Fertility Centre   (Greece)

^d Laboratory of Reproductive Biology University Hospital of Copenhagen University of Copenhagen ^*  (United Kingdom)

^e NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; EUROVITAL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; PRASTERONE; PROGESTERONE; UNCLASSIFIED DRUG;

ABDOMINAL RADICAL CERVICAL TRACHELECTOMY; ABDOMINAL SURGERY; ADRENAL FUNCTION; ADULT; ARTICLE; CANCER STAGING; CANCER SURGERY; CASE REPORT; CRYOPRESERVATION; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LIMIT OF DETECTION; LYMPH NODE DISSECTION; NULLIPARA; OOCYTE RETRIEVAL; OVARIAN RESERVE; POSTMENOPAUSE; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SALPINGOOOPHORECTOMY; TISSUE PRESERVATION; UTERINE CERVIX CANCER; BIOSYNTHESIS; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; OVARY; PARITY; PREGNANCY; TRANSPLANTATION;

ADULT; CRYOPRESERVATION; DEHYDROEPIANDROSTERONE; FEMALE; HUMANS; OVARIAN RESERVE; OVARY; PARITY; PREGNANCY; PROGESTERONE;

EID: 84904116315     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-014-0214-3     Document Type: Article

References (17)

1. Rosendahl M, Schmidt KT, Ernst E, Rasmussen PE, Loft A, Byskov AG, et al. Cryopreservation of ovarian tissue for a decade in Denmark - an overview of the technique. Reprod Med Online. 2011;22:162-71.
2. Andersen CY, Silber SJ, Berghold SH, Jorgensen JS, Ernst E. Longterm duration of function of ovarian tissue transplants: case reports. Reprod Biomed Online. 2012;25:128-32.
3. Donnez J, Dolmans MM, Pellicer A, Diaz C, Sanchez M, Schmidt KT, et al. Restoration of ovarian activity and pregnancies after transplantation of cryopreserved ovarian tissue. A review. Fertil Steril. 2013;99:1503-13.
4. Greve T, Schmidt KT, Kristensen SG, Ernst E, Andersen CY. Evaluation of the ovarian reserve in women transplanted with frozen and thawed ovarian cortical tissue. Fertil Steril. 2012;97:1394-8.
5. Sönmezer M, Ozmen B, Cil AP, Ozkavukçu S, Taşçi T, Olmuş H, et al. Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders. Reprod Biomed Online. 2009;19:508-13.
6. Gleicher N, Kim A, Weghofer A, Shohat-Tal A, Lazzaroni E, Lee HJ, et al. Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR). J Assist Reprod Genet. 2013;30:49-62.
7. Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol. 2011;9:67.
8. Nielsen ME, Rasmussen IA, Kristensen SG, Christensen ST, Møllgård K, Wreford Andersen E, et al. Expression of androgen-receptor mRNA in granulosa cells from human small antral follicles and the corresponding follicular fluid concentrations of androgens are positively correlated to granulosa cell FSH receptor mRNA expression. Mol Hum Reprod. 2011;17:63-70.
9. Panjari M, Davis SR. DHEA therapy for women: effect on sexual function and wellbeing. Hum Reprod Update. 2007;13:239-48. (Pubitemid 47071610)
10. Schmidt KLT, Yding Andersen C, Starup J, Loft A, Byskov AG, Nyboe Andersen A. Orthotophic autotransplantation of cryopreserved ovarian tissue to a woman cured of cancer. Follicular growth, steroid production and oocyte retrieval. Reprod Biomed Online. 2004;8:448-53. (Pubitemid 38477195)
11. Genazzani AR, Pluchino N, Begliuomini S, Stomati M, Bernardi F, Pieri M, et al. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol. 2006;22:627-35. (Pubitemid 44915729)
12. Rosendahl M, Loft A, Byskov AG, Ziebe S, Schmidt KT, Andersen AN, et al. Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: case report. Hum Reprod. 2006;21:2006-9. (Pubitemid 44288073)
13. Genazzani AR, Inglese S, Lombardi I, Pieri M, Bernardi F, Genazzani AD, et al. Long-term low-dose dehydroepiandrosterone replacement therapy in agingmales with partial androgen deficiency. Aging Male. 2004;7:133-43. (Pubitemid 39272936)
14. Labrie F, Labrie C. DHEA and intracrinology at menopause, a positive choice for evolution of the human species. Climacteric. 2013;16:205-13.
15. Mahesh VB. Hirsutism, virilism, polycystic ovarian disease, and the steroid-gonadotropin-feedback system: a career retrospective. Am J Physiol Endocrinol Metab. 2012;302:E4-18.
16. Bosch E, Labarta E, Crespo J, Simón C, Remohí J, Jenkins J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010;25:2092-100.
17. Yding Andersen C, Bungum L, Nyboe Andersen A, Humaidan P. Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate. Reprod Biomed Online. 2011;23:187-95.